Alternate paths from epidermal growth factor receptor to Akt in malignant versus nontransformed lung epithelial cells: ErbB3 versus Gab1.
about
Constitutive androstane receptor ligands modulate the anti-tumor efficacy of paclitaxel in non-small cell lung cancer cells.RNA interference against hepatic epidermal growth factor receptor has suppressive effects on liver regeneration in ratsKey roles for GRB2-associated-binding protein 1, phosphatidylinositol-3-kinase, cyclooxygenase 2, prostaglandin E2 and transforming growth factor alpha in linoleic acid-induced upregulation of lung and breast cancer cell growth.Molecular effects of doxycycline treatment on pterygium as revealed by massive transcriptome sequencing.Curcumin and vitamin E protect against adverse effects of benzo[a]pyrene in lung epithelial cells.Anti-tumor efficacy of naked siRNAs for ERBB3 or AKT2 against lung adenocarcinoma cell xenografts.Non-coding rRNA-mediated preferential killing in cancer cells is enhanced by suppression of autophagy in non-transformed counterpart.Stabilization of ribozyme-like cis-noncoding rRNAs induces apoptotic and nonapoptotic death in lung cells.Acquired substrate preference for GAB1 protein bestows transforming activity to ERBB2 kinase lung cancer mutants.The ERBB3 receptor in cancer and cancer gene therapyBiphasic regulation of ENaC by TGF-{alpha} and EGF in renal epithelial cells.ERBB3-independent activation of the PI3K pathway in EGFR-mutant lung adenocarcinomasTranscriptionally inducible Pleckstrin homology-like domain family A member 1 attenuates ErbB receptor activity by inhibiting receptor oligomerization.The Rac1/JNK pathway is critical for EGFR-dependent barrier formation in human airway epithelial cells.
P2860
Q33799970-DF18E80C-8B63-459D-AE1C-29E6DF60FA40Q33882396-AC3C008B-6379-4826-8614-13FC761AC903Q34069510-5AC5A236-320E-42BB-8AE0-9CB14182DE15Q34314409-BE7AC830-5D56-4D3A-B808-C025D4E61D96Q35130302-BA30DD71-4934-42BD-8A74-E011FCA2F7CEQ35563891-8CE2C203-6041-4F7F-8C30-A9B1D9830708Q35657091-E637878B-A6A3-4531-A791-2703A5C40EAFQ35865234-215DCEE4-33BB-4E29-B261-81888B0E9A15Q36910173-48D46DE4-A61E-4BA7-A091-FA02C3B967D3Q37135372-ECA4C0FD-12B2-4346-9515-08A7D01CCC0FQ37216890-D5118C56-B9E2-4E42-B428-3DF865EA0F8CQ38919117-D24BCC58-CED7-4B3A-B025-FE40BE39446FQ47256372-53B9F344-A3BA-47DA-96FF-F3749A4E5D73Q54636790-F509F268-5661-4CB9-8961-C12D0E5F2A7D
P2860
Alternate paths from epidermal growth factor receptor to Akt in malignant versus nontransformed lung epithelial cells: ErbB3 versus Gab1.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 July 2005
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Alternate paths from epidermal ...... lial cells: ErbB3 versus Gab1.
@en
Alternate paths from epidermal ...... lial cells: ErbB3 versus Gab1.
@nl
type
label
Alternate paths from epidermal ...... lial cells: ErbB3 versus Gab1.
@en
Alternate paths from epidermal ...... lial cells: ErbB3 versus Gab1.
@nl
prefLabel
Alternate paths from epidermal ...... lial cells: ErbB3 versus Gab1.
@en
Alternate paths from epidermal ...... lial cells: ErbB3 versus Gab1.
@nl
P2093
P2860
P356
P1476
Alternate paths from epidermal ...... lial cells: ErbB3 versus Gab1.
@en
P2093
George T Smith
Gunamani Sithanandam
Janet R Fields
Laura W Fornwald
Lucy M Anderson
P2860
P304
P356
10.1165/RCMB.2005-0049OC
P577
2005-07-29T00:00:00Z